Article ID Journal Published Year Pages File Type
10962727 Vaccine 2016 12 Pages PDF
Abstract
Microneedle technology research has been focussed on demonstrating efficacy with minimal focus on determining HCP/public perception and acceptability for paediatric use, exemplified by the paucity of studies presented in this review. Commercial viability will depend on HCP/public acceptability of microneedle technology. An effort must be made to identify the barriers to acceptance and to overcome them by increasing awareness and education in stakeholder groups pertaining to the paediatric population.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , ,